A TNFR2 Antibody by Countering Immunosuppression Cooperates with HMGN1 and R848 Immune Stimulants to Inhibit Murine Colon Cancer

0
252
Scientists examined the efficacy of TY101 as an anti-tumor immune reagent combined with HMGN1and R848.
[International Immunopharmacology]
Abstract